6,173
Views
5
CrossRef citations to date
0
Altmetric
Clinical focus: Musculoskeletal conditions - Review

The role of osteoanabolic agents in the management of patients with osteoporosis

, , , , , ORCID Icon & show all
Pages 541-551 | Received 15 Dec 2021, Accepted 20 Apr 2022, Published online: 30 May 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Andrea J. Singer, Anita Sharma, Cynthia Deignan & Liesbeth Borgermans. (2023) Closing the gap in osteoporosis management: the critical role of primary care in bone health. Current Medical Research and Opinion 39:3, pages 387-398.
Read now

Articles from other publishers (4)

J. Lane, B. Langdahl, M. Stone, A. Kurth, M. Oates, J. Timoshanko, Z. Wang, C. Libanati & F. Cosman. (2024) Romosozumab in patients who experienced an on-study fracture: post hoc analyses of the FRAME and ARCH phase 3 trials. Osteoporosis International.
Crossref
Mihaela Stanciu, Florica Sandru, Mara Carsote, Adrian Ciuche, Oana-Claudia Sima, Florina Ligia Popa, Mădălina Gabriela Iliescu, Nicolae Ciufu & Claudiu Nistor. (2023) Difficulties in decision making on a long standing, complicated case of osteoporosis – a real challenge for functional rehabilitation. Balneo and PRM Research Journal 14:Vol.14, no. 4, pages 642.
Crossref
Jesús González Macías & José Manuel Olmos Martínez. (2023) Romosozumab: confusion regarding its indications. Revista de Osteoporosis y Metabolismo Mineral.
Crossref
E. Michael Lewiecki, John P. Bilezikian, Neil Binkley, Mary L. Bouxsein, Susan V. Bukata, David W. Dempster, Matthew T. Drake, Michael R. McClung, Paul D. Miller, Elisabeth Rosenthal & Laura L. Tosi. (2022) Proceedings of the 2022 Santa Fe Bone Symposium: Current Concepts in the Care of Patients with Osteoporosis and Metabolic Bone Diseases. Journal of Clinical Densitometry 25:4, pages 649-667.
Crossref